What is LH stock price today?

LH (Labcorp Holdings Inc) stock is trading at $289.12 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LH stock going up or down today?

LH stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LH stock now?

The decision to buy LH depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LH a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LH based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LH stock overvalued or undervalued?

LH currently trades at a P/E ratio of 27.47, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LH is fairly priced.

What is LH's P/E ratio?

LH has a price-to-earnings (P/E) ratio of 27.47, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is LH's market cap?

LH (Labcorp Holdings Inc) has a market capitalization of $23.84 billion, making it a mid-cap stock.

What is LH's price to book ratio?

LH trades at a price-to-book (P/B) ratio of 2.74, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LH pay dividends?

Yes, LH pays dividends with a current yield of 0.01%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is LH's dividend yield?

LH's dividend yield is 0.01%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is LH stock a good long-term investment?

LH's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LH's revenue growth rate?

LH has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, LH is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in LH?

Key risks for LH include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LH compare to its competitors?

Compare LH to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LH's performance and positioning.

What is LH's stock price target for 2026?

Our AI model provides price targets for LH based on fundamental analysis: Bull case $375.86 (+30%), Base case $332.49 (+15%), Bear case $260.21 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LH?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LH. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LH's next earnings report?

LH reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LH - Labcorp Holdings Inc

NYSE * Health Care * Life Sciences Tools & Services

$289.12

+$1.50 (+0.52%)

About Labcorp Holdings Inc

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

LH Key Statistics

Market Cap

$23.84B

P/E Ratio

27.47

P/B Ratio

2.74

EPS

$10.47

Dividend Yield

0.01%

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

71,000

How LH Compares to Peers

LH has the lowest P/E ratio in Life Sciences Tools & Services, suggesting it may be the most undervalued

LH is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
LH(This stock)	$23.84B	27.5	0%	0.1%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Labcorp Holdings Inc Company Information

Headquarters: North Carolina; U.S.A
Website: www.labcorp.com
Sector: Health Care
Industry: Life Sciences Tools & Services

LH - Labcorp Holdings Inc

About Labcorp Holdings Inc

LH Key Statistics

How LH Compares to Peers

Labcorp Holdings Inc Company Information

LH Lician Score

LH Financial Snowflake

Upcoming Events for LH